A prospective, open label, randomized phase II trial of weekly docetaxel versus weekly vinorelbine as first line chemotherapy in patients with androgen independent prostate cancer (Q80350305)
Jump to navigation
Jump to search
scientific article published on 01 June 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A prospective, open label, randomized phase II trial of weekly docetaxel versus weekly vinorelbine as first line chemotherapy in patients with androgen independent prostate cancer |
scientific article published on 01 June 2007 |
Statements
A prospective, open label, randomized phase II trial of weekly docetaxel versus weekly vinorelbine as first line chemotherapy in patients with androgen independent prostate cancer (English)
Sandra Tomek
Katarzyna Elandt
Walter Albrecht
Michael Eisenmenger
Wolfgang Höltl
Paul Schramek
Walter Stackl
Christoph Zielinski
Jochen Reibenwein
2141-5; discussion 2145